135 Participants Needed

Ephedrine for Childbirth

Recruiting at 1 trial location
Daniel Katz - Anesthesiology | Mount ...
Overseen ByDaniel Katz, MD
Age: 18 - 65
Sex: Female
Trial Phase: Phase 4
Sponsor: Icahn School of Medicine at Mount Sinai
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Labor analgesia is an important component of the care of laboring patients. A known side effect of combined spinal and epidural anesthesia (a type of labor analgesia) is an increased incidence of category II fetal heart rate tracing (defined below) and low blood pressure. The study team aims to study if a prophylactic dose of ephedrine will decrease the occurrence of this type of tracing after combined spinal epidural (CSE) anesthesia placement. Ephedrine is not currently routinely used as prevention for category II tracings or low blood pressure. The use of Ephedrine in this study is investigational (this is the first time that the drug has been studied for its effect on these conditions). Fetal heart rate (FHR) tracings are classified into three categories. In clinical practice, FHR tracing categories are used as a guide to obstetric management and suggest the following approach: * Category I tracing is "reactive" and reassuring → may continue labor * Category II tracing is neither category I nor category III. For obvious reasons, category II is the broadest and largest category, consisting of various FHR tracing patterns that do not fit into either category I or category III. * Category III tracing is non-reassuring → expedited vaginal or cesarean delivery recommended. A Category II tracing is not diagnostic. Most pregnancies have at least one Category II tracing. There is not always an identifiable reason for a Category II tracing. Ephedrine is a medication that causes an increase in heart rate and blood pressure while also causing some degree of relaxation of the uterus therefore improving uterine blood flow. It has been used in the obstetric population for over 50 years without issues. The dose that the research team will administer, 7.5 mg, is below the dose the research team will often administer to treat hypotension (low blood pressure).

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

What evidence supports the effectiveness of the drug Ephedrine for childbirth?

Ephedrine, derived from Ephedrae herba, has been traditionally used to treat colds, asthma, and nasal congestion, suggesting its potential effectiveness in managing symptoms related to respiratory issues. However, there is no direct evidence from the provided research supporting its effectiveness specifically for childbirth.12345

Is ephedrine safe for use in humans?

Ephedrine, found in the herb Ephedra, has been used for treating colds and asthma but can cause adverse effects like palpitations, stress, headache, and insomnia. Serious reactions such as heart attacks and seizures have been reported, especially when combined with caffeine or other stimulants, leading to recalls of some products.13567

How is the drug Ephedrine unique for childbirth compared to other treatments?

Ephedrine, derived from the Ephedra plant, is unique because it has been traditionally used for respiratory conditions like asthma and colds, and its effectiveness can vary based on the plant's growing conditions, which affect its alkaloid content. This variability in its chemical composition might offer different pharmacological effects compared to standard treatments for childbirth.12389

Research Team

JL

James Leader

Principal Investigator

Icahn School of Medicine at Mount Sinai

Eligibility Criteria

This trial is for women aged 18-55 years in labor who want pain relief and can give informed consent. They must have a reassuring 'Category I' fetal heart rate before getting anesthesia. Women with suspected pre-eclampsia, non-reassuring 'Category II or III' fetal heart rates, or a history of high blood pressure cannot participate.

Inclusion Criteria

I am a woman aged between 18 and 55.
Requesting labor analgesia
Able to provide informed written consent
See 1 more

Exclusion Criteria

I have chosen not to receive spinal or epidural anesthesia.
I have a history of high blood pressure.
Suspected pre-eclampsia
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either ephedrine or placebo after combined spinal epidural anesthesia to study its effects on fetal heart rate tracing and blood pressure

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including blood pressure and heart rate changes

6 months

Treatment Details

Interventions

  • Ephedrine
  • Normal Saline Placebo
Trial OverviewThe study tests if giving ephedrine before combined spinal epidural anesthesia can prevent certain changes in the baby's heart rate and mother's blood pressure during childbirth. Ephedrine has been used safely for over 50 years but its preventive use here is new.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: EphedrineExperimental Treatment1 Intervention
3 minutes after the placement of a combined spinal epidural with 25 mcg fentanyl, 7.5 mg ephedrine IV will be administered to the patient, 12 minutes later, a second dose of 7.5mg will be administered to the patient as long as the patient is not hypertensive (BP no greater than 140/90)
Group II: PlaceboPlacebo Group1 Intervention
3 minutes after the placement of a combined spinal epidural with 25 mcg fentanyl, 2.5cc 0.9% NS IV will be administered to the patient, 12 minutes later, a second dose of , 2.5cc 0.9% NS will be administered to the patient.

Ephedrine is already approved in United States, Canada for the following indications:

🇺🇸
Approved in United States as Ephedrine for:
  • Hypotension
  • Bronchial asthma
  • Narcolepsy
  • Myasthenia gravis
  • Allergic disorders
🇨🇦
Approved in Canada as Ephedrine for:
  • Nasal decongestant
  • Asthma
  • Bronchitis

Find a Clinic Near You

Who Is Running the Clinical Trial?

Icahn School of Medicine at Mount Sinai

Lead Sponsor

Trials
933
Recruited
579,000+

Findings from Research

Ephedrae herba, a traditional Chinese herb, contains over 281 chemical constituents, with alkaloids and volatile oils being the most bioactive, and is used for treating conditions like colds and bronchial asthma.
While Ephedrae herba has multiple pharmacological effects, including anti-inflammatory and anti-viral properties, it can cause adverse reactions if overused, highlighting the importance of adhering to a maximum dosage of 10 g.
Ephedrae herba: A comprehensive review of its traditional uses, phytochemistry, pharmacology, and toxicology.Zheng, Q., Mu, X., Pan, S., et al.[2023]
The Ephedra-Gypsum herb-pair demonstrated significant antipyretic effects in a study with 30 male Wistar rats, effectively reducing yeast-induced fever in a dose-dependent manner.
In an ovalbumin-induced asthmatic model with 36 male SD rats, Ephedra-Gypsum extracts improved asthma symptoms by reducing eosinophil counts and lung weight ratios, indicating its potential as an effective treatment for bronchial asthma.
Antipyretic and anti-asthmatic activities of traditional Chinese herb-pairs, Ephedra and Gypsum.Mei, F., Xing, XF., Tang, QF., et al.[2018]
The study investigated how different ratios of the Mahuang-Guizhi herb-pair affect the bioavailability of five ephedrine alkaloids in rats, revealing significant differences in pharmacokinetic parameters like plasma concentration and half-life.
These findings suggest that adjusting the ratios of Mahuang and Guizhi can optimize the therapeutic effects while potentially reducing toxicity, paving the way for improved formulations in treating conditions like asthma and cough.
Pharmacokinetic comparisons of five ephedrine alkaloids following oral administration of four different Mahuang-Guizhi herb-pair aqueous extracts ratios in rats.Wei, P., Huo, HL., Ma, QH., et al.[2019]

References

Ephedrae herba: A comprehensive review of its traditional uses, phytochemistry, pharmacology, and toxicology. [2023]
Antipyretic and anti-asthmatic activities of traditional Chinese herb-pairs, Ephedra and Gypsum. [2018]
Pharmacokinetic comparisons of five ephedrine alkaloids following oral administration of four different Mahuang-Guizhi herb-pair aqueous extracts ratios in rats. [2019]
Comparative tissue distribution and excretion study of alkaloids from Herba Ephedrae-Radix Aconiti Lateralis extracts in rats. [2017]
Simultaneous quantification and pharmacokinetics of alkaloids in Herba Ephedrae-Radix Aconiti Lateralis extracts. [2017]
Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. [2022]
[Ephedrine and ephedra in weight loss products and other preparations]. [2013]
[Quality evaluation of twelve species of Chinese Ephedra (ma huang)]. [2017]
Studies of Ephedra plants in Asia. Part 6: Geographical changes of anatomical features and alkaloids content of Ephedra sinica. [2021]